Gift or transfer — classified separately from trades.
Traded Nov 13, 2025 · Filed Nov 14, 2025
Thermo Fisher Scientific's Executive Vice President & COO sold $2.76M of Thermo Fisher Scientific shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,756,920
Shares × reported transaction price
22 days after results of Oct 22, 2025, 77 days before results of Jan 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $580.13 on Nov 13, 2025, within 5% of its 52-week high, after an 11% rise over the previous 30 trading days
52-week range $390.26 (Jun 17, 2025) to $606.74 (Jan 30, 2025), 88% of the way up, from 250 adjusted closes. 30 trading days earlier: $524.96 on Oct 2, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.3% | +0.5% | +2.9% |
| 30 days | -0.8% | +0.9% | -1.7% |
| 90 days | -11.6% | +2.6% | -14.1% |
| 180 days | -22.1% | +11.0% | -33.0% |
Past results only. Not a forecast.
Gift or transfer — classified separately from trades.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.